Ikarian Capital, LLC
CIK 1778253
13F filing for Q2 2026・No. 2,696
- Holdings
- US$928.17M
- Quarter change
- −US$303.51M
- Entries
- 156
- Net bought (estimate)
- −US$115.08M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 27
- Sold out 28
- Cut 29
- Added 18
- Corporate actions 0
- Unchanged 52
Largest holdings
126 stocks worth US$610.87M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| ABIVAX SASPONSORED ADS | Added | 328,635 | US$43.35M | 7.10% |
| KODIAK SCIENCES INCCOM | Cut | 1,059,730 | US$41.29M | 6.76% |
| ALUMIS INCCOM | Cut | 870,548 | US$24.5M | 4.01% |
| PRAXIS PRECISION MEDICINES ICOM NEW | Added | 72,842 | US$24.39M | 3.99% |
| PCVXVAXCYTE INCCOM | Cut | 388,682 | US$22.59M | 3.70% |
| ANI PHARMACEUTICALS INCCOM | Added | 272,085 | US$22.52M | 3.69% |
| CELLDEX THERAPEUTICS INC NEWCOM NEW | Added | 478,500 | US$17.8M | 2.91% |
| ARCUS BIOSCIENCES INCCOM | New | 504,559 | US$15.56M | 2.55% |
| RELMADA THERAPEUTICS INCCOM | Cut | 2,148,359 | US$14.87M | 2.43% |
| CAPRICOR THERAPEUTICS INCCOM NEW | Added | 604,215 | US$14.55M | 2.38% |
Sign in (free) to see its 50 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.